Clinical trial
TREATMENT OF ALL IN FIRST BONE MARROW RELAPSE AFTER BFM PROTOCOLS
NCT00002499 is registered in ClinicalTrials.gov with Grupo Argentino de Tratamiento de la Leucemia Aguda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TREATMENT OF ALL IN FIRST BONE MARROW RELAPSE AFTER BFM PROTOCOLS
- Lead sponsor
- Grupo Argentino de Tratamiento de la Leucemia Aguda
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- January 31, 1990
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.